Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase NA 7Phase 3 4Phase 4 1Phase 2/3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 29INDUSTRY 18OTHER_GOV 1NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Leukemia, Myeloid, Acute 2Carcinoma, Hepatocellular 2Weight Loss 1Warts 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Oesophagogastric Cancer 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lung Neoplasms 1Leukopenia 1Leukemia, Promyelocytic, Acute 1Leukemia, Biphenotypic, Acute 1Insulin Resistance 1Infertility 1Immunotherapy Gastrict Cancer 1Hydatidiform Mole 1Glioma 1

Interventions

Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER_GOV × Neoplasm Metastasis × Clear all
NCT03491410 2018-04-09

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Centro Hospitalar Lisboa Ocidental

Phase 2/3 Unknown
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡